These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38760750)

  • 21. A pharmacoepidemiologic study of community-dwelling, disabled older women: Factors associated with medication use.
    Crentsil V; Ricks MO; Xue QL; Fried LP
    Am J Geriatr Pharmacother; 2010 Jun; 8(3):215-24. PubMed ID: 20624611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polypharmacy including falls risk-increasing medications and subsequent falls in community-dwelling middle-aged and older adults.
    Richardson K; Bennett K; Kenny RA
    Age Ageing; 2015 Jan; 44(1):90-6. PubMed ID: 25313240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of polypharmacy and associated adverse health outcomes in adult patients with chronic kidney disease: protocol for a systematic review and meta-analysis.
    Okpechi IG; Tinwala MM; Muneer S; Zaidi D; Ye F; Hamonic LN; Khan M; Sultana N; Brimble S; Grill A; Klarenbach S; Lindeman C; Molnar A; Nitsch D; Ronksley P; Shojai S; Soos B; Tangri N; Thompson S; Tuot D; Drummond N; Mangin D; Bello AK
    Syst Rev; 2021 Jul; 10(1):198. PubMed ID: 34218816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cumulative Cardiovascular Polypharmacy Is Associated With the Risk of Acute Kidney Injury in Elderly Patients.
    Chao CT; Tsai HB; Wu CY; Lin YF; Hsu NC; Chen JS; Hung KY
    Medicine (Baltimore); 2015 Aug; 94(31):e1251. PubMed ID: 26252287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polypharmacy, chronic kidney disease, and mortality among older adults: A prospective study of National Health and nutrition examination survey, 1999-2018.
    Wang X; Yang C; Jiang J; Hu Y; Hao Y; Dong JY
    Front Public Health; 2023; 11():1116583. PubMed ID: 37033012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of Polypharmacy with Kidney Disease Progression in Adults with CKD.
    Kimura H; Tanaka K; Saito H; Iwasaki T; Oda A; Watanabe S; Kanno M; Shimabukuro M; Asahi K; Watanabe T; Kazama JJ
    Clin J Am Soc Nephrol; 2021 Dec; 16(12):1797-1804. PubMed ID: 34782408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patterns of drug use and polypharmacy burden in chronic kidney disease patients: An experience from a secondary care hospital in United Arab Emirates.
    Shouqair TM; Rabbani SA; Kurian MT
    Int J Clin Pharmacol Ther; 2021 Jul; 59(7):519-529. PubMed ID: 33835017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polypharmacy, chronic kidney disease, and incident fragility fracture: a prospective cohort study.
    Wakasugi M; Yokoseki A; Wada M; Momotsu T; Sato K; Kawashima H; Nakamura K; Onodera O; Narita I
    J Bone Miner Metab; 2022 Jan; 40(1):157-166. PubMed ID: 34729651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of high-risk medications on mortality risk among older adults with polypharmacy: evidence from the English Longitudinal Study of Ageing.
    Huang YT; Steptoe A; Wei L; Zaninotto P
    BMC Med; 2021 Dec; 19(1):321. PubMed ID: 34911547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kidney function and other factors and their association with falls : The screening for CKD among older people across Europe (SCOPE) study.
    Britting S; Artzi-Medvedik R; Fabbietti P; Tap L; Mattace-Raso F; Corsonello A; Lattanzio F; Ärnlöv J; Carlsson AC; Roller-Wirnsberger R; Wirnsberger G; Kostka T; Guligowska A; Formiga F; Moreno-Gonzalez R; Gil P; Martinez SL; Kob R; Melzer I; Freiberger E;
    BMC Geriatr; 2020 Oct; 20(Suppl 1):320. PubMed ID: 33008307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Self-reported medication in community-dwelling older adults in Germany: results from the Berlin Initiative Study.
    Mielke N; Huscher D; Douros A; Ebert N; Gaedeke J; van der Giet M; Kuhlmann MK; Martus P; Schaeffner E
    BMC Geriatr; 2020 Jan; 20(1):22. PubMed ID: 31964342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and factors associated with polypharmacy in the older people: 2006-2014.
    Carmona-Torres JM; Cobo-Cuenca AI; Recio-Andrade B; Laredo-Aguilera JA; Martins MM; Rodríguez-Borrego MA
    J Clin Nurs; 2018 Aug; 27(15-16):2942-2952. PubMed ID: 29603814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The association between polypharmacy and health-related quality of life among non-dialysis chronic kidney disease patients.
    Adjeroh L; Brothers T; Shawwa K; Ikram M; Al-Mamun MA
    PLoS One; 2023; 18(11):e0293912. PubMed ID: 37956162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low health literacy and multiple medications in community-dwelling older adults: a population-based cohort study.
    Shebehe J; Montgomery S; Hansson A; Hiyoshi A
    BMJ Open; 2022 Feb; 12(2):e055117. PubMed ID: 35190435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in clinical outcomes for community-dwelling older people exposed to incident chronic polypharmacy: a comparison between 2001 and 2009.
    Franchi C; Marcucci M; Mannucci PM; Tettamanti M; Pasina L; Fortino I; Bortolotti A; Merlino L; Nobili A
    Pharmacoepidemiol Drug Saf; 2016 Feb; 25(2):204-11. PubMed ID: 26687829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multimorbidity patterns, polypharmacy and their association with liver and kidney abnormalities in people over 65 years of age: a longitudinal study.
    Villén N; Guisado-Clavero M; Fernández-Bertolín S; Troncoso-Mariño A; Foguet-Boreu Q; Amado E; Pons-Vigués M; Roso-Llorach A; Violán C
    BMC Geriatr; 2020 Jun; 20(1):206. PubMed ID: 32532213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potentially Inappropriately Prescribed Medications Among Medicare Medication Therapy Management Eligible Patients with Chronic Kidney Disease: an Observational Analysis.
    Silva-Almodóvar A; Hackim E; Wolk H; Nahata MC
    J Gen Intern Med; 2021 Aug; 36(8):2346-2352. PubMed ID: 33506400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute Kidney Injury and Chronic Kidney Disease in the Elderly and Polypharmacy.
    Formica M; Politano P; Marazzi F; Tamagnone M; Serra I; Marengo M; Falconi D; Gherzi M; Tattoli F; Bottaro C; Giuliano D; Tibaldi V; Isaia GC
    Blood Purif; 2018; 46(4):332-336. PubMed ID: 30176676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of Potentially Inappropriate Medications on Kidney Function in Chronic Kidney Disease: Retrospective Cohort Study.
    Kimura H; Yoshida S; Takeuchi M; Kawakami K
    Nephron; 2023; 147(3-4):177-184. PubMed ID: 36116436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mild chronic kidney disease and functional impairment in community-dwelling older adults.
    Smyth A; Glynn LG; Murphy AW; Mulqueen J; Canavan M; Reddan DN; O'Donnell M
    Age Ageing; 2013 Jul; 42(4):488-94. PubMed ID: 23438445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.